Geron | GERN - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Amgen USD 12.04B 2.91B 2026-03
Bio Techne USD 209.82M 36.94M 2026-03
Cassava Sciences USD 86.57M 8.93M 2026-03
Cytokinetics USD 129.84M 7.32M 2026-03
Esperion Therapeutics USD 156.16M 11.69M 2026-03
Exelixis USD 226.15M 256.34M 2026-03
Genmab DKK 1.72B 46M 2025-12
Geron USD 68.9M 10.54M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Incyte USD 4.02B 435.22M 2026-03
MacroGenics USD 66.52M 9.3M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Novavax USD 228.36M 12.27M 2026-03